Adare Pharma Solutions, a global contract development and manufacturing organization (CDMO), is committed to advancing oral solid dose pharmaceuticals through integrated, end-to-end services. Specializing in small molecule oral dosage forms, Adare supports pharmaceutical companies from early development through commercial manufacturing and packaging.

With seven facilities across the United States and Europe, Adare offers secure and flexible supply chain solutions tailored to global and regional markets. The company has successfully developed and manufactured over 65 products for clients worldwide.

Adare’s expertise spans tablets, capsules, multiparticulates, and Minitabs, with a focus on patient-centric formulations that improve adherence and therapeutic outcomes. Its integrated CDMO model enables seamless scale-up, efficient tech transfers, and consistent quality across all sites, supported by harmonized standards and rigorous compliance protocols.

Dedicated project managers provide unified oversight throughout each engagement, ensuring alignment and transparency. Adare’s customer-focused approach emphasizes collaboration, adaptability, and tailored solutions to meet the evolving needs of the pharmaceutical industry.